Browse drugs

…its, BMI, diabetes duration, HbA1c, ACR, triglycerides, LDL and statins treatment. Linear regression models on eGFR decline were perfor…

…duals at borderline or intermediate risk of ASCVD.16 Similarly, FIB-4 may serve an analogous role in nephrology by identifying patien…

…mean age <40 years (WMD=−1.60, 95% CI −1.98 to −1.22; p<0.001). Statins lowered CRP in both controlled before-after studies (standardis…

…o evaluate the efficacy of vascular-targeted pharmacotherapies (statins, phosphodiesterase-4 inhibitors, long-acting bronchodilators). …

…cribed (%) N = 76 Improvement (%) p-value Significant? (p<0.05) Aspirin 221 (100) 76 (100) 0 - - Beta-blocker 156 (70.6) 69 (90.8) +20.…

…ts with pCHD were less likely to be prescribed SP medication of statins, antihypertensives and antiplatelets.…

…CE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), statins) and treatment targets (blood pressure (BP) and HbA1c). Pooled …

…excluded to minimize misclassification of gestational diabetes. Metformin dispensations alone before age 40 were disregarded in women wit…

…with routine medications—statins, cyclo-oxygenase-2 inhibitors, beta-blockers—remain poorly understood. Whether overnight in-bedroom PM2.5 ai…

… 1.61) for screening attendance, 1.50 (0.98 to 2.29) for use of statins, and 0.95 (0.32 to 2.79) for incidence of disease. For psycholo…

…<2.6 mmol/L, triglyceride concentration <2.0 mmol/L, and use of renin-angiotensin system inhibitors.JADE, Joint Asia Diabetes Evaluation; MET, metabolic equivalent…

…lear need to standardise post MI management of HRT in hospitals.Oestrogen affects remodelling and thrombogenesis in a dose dependent risk…